"Hepatocellular carcinomas that are not amenable to definitive therapy with thermal ablation or resection can be treated with trans-arterial chemoembolization (TACE). The end goal may be palliation or downstaging to meet liver transplantation criteria, depending on the situation."
"LR-TR viable: nodular or masslike enhancement in the treatment zone with arterial phase hyperenhancement, wash out on the portal venous phase, or enhancement similar to the pre-treatment lesion"
"Post-TACE assessment of hepatocellular carcinomas is essential for evaluating the success of the therapy."
"orthogonal (bidimensional) measurements (EASL)"